Major depressive disorder (MDD) is the most common major mental illness, afflicting almost one in five individuals. More than 75% of people who recover from an episode of MDD will have at least one recurrence, with the majority having multiple recurrences. MDD is the leading cause of disability of
read more »
Source:http://www.medicalnewstoday.com DiscussBury
Countless movies and TV shows make light of women's so-called "moodiness", often jokingly attributing it to their menstrual cycle or, conversely, to menopause. In fact, mood disorders are a serious and pervasive health problem, and large-scale population studies have found women are 1.5 to 3 times
read more »
Source:http://www.medicalnewstoday.com DiscussBury
Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), announces that data from two Phase 3 clinical studies of PRISTIQ(TM) (desvenlafaxine), an investigational serotonin-norepinephrine reuptake inhibitor (SNRI), showed that adult patients who received a 50 mg/day dose of PRISTIQ for the treatme
read more »
Source:http://www.medicalnewstoday.com DiscussBury
Psychiatrists remain divided as to how to define and classify the mood and anxiety disorders, the most common mental disorders. Committees across the globe are currently pondering how best to carve nature at its anxious joints for the fifth version of the Diagnostic and Statistical Manual (DSM-V),
read more »
Source:http://www.medicalnewstoday.com DiscussBury
The 2007 American College of Neuropsychopharmacology Annual Meeting featured hundreds of new studies on brain and behavior from the world's leading scientists. Presentations included innovative research on potential new treatments for depression, post-traumatic stress disorder, autism and addiction
read more »
Source:http://www.medicalnewstoday.com DiscussBury
Depression nearly triples the risk of death following a heart attack, even when accounting for other heart attack risk factors, according to research presented at the American College of Neuropsychopharmacology (ACNP) annual meeting, which showed that among 360 depressed, post myocardial infarction
read more »
Source:http://www.medicalnewstoday.com DiscussBury
Researchers may be able to develop an antidepressant which takes effect almost immediately by directly targeting novel molecules in the brain instead of taking a less direct route, which can lead to longer times for medication to take effect, according to a new study presented at the American Colle
read more »
Source:http://www.medicalnewstoday.com DiscussBury
The first data from the SEROQUEL XR™ (quetiapine fumarate) Extended Release clinical development programme in major depressive disorder (MDD)1,2 and generalised anxiety disorder (GAD)3 were presented at the 7th International Forum on Mood and Anxiety Disorders (IFMAD) in Budapest, AstraZeneca annou
read more »
Source:http://www.medicalnewstoday.com DiscussBury
New data released reinforces the superiority of escitalopram compared to duloxetine in the acute treatment of depression and provides a further insight into the impact of antidepressants on patient functioning and quality of life - an important consideration for physicians and patients. [click link
read more »
Source:http://www.medicalnewstoday.com DiscussBury
Medinews is an online community dedicated for promoting and discussing latest medical news, research articles and blogs. You can also find regular updates on health news for discussion by health professionals.